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Abstract 
Data science extracts new knowledge from high dimensional datasets through 
computer science and statistics. Mental health research, diagnosis and treatment 
can benefit from data science data integration from consented cohort studies, 
genomics, routine healthcare and administrative data. The UK is well placed to 
do so through exemplary data science projects, such as UK Biobank, Generation 
Scotland, ALSPAC and CRIS, set within the UK National Health Service. The NHS 
ensures the highest standards of data governance, public trust and value, 
establishing the ideal platform for the advancement of mental health through 
data science. Data science has great potential as a low cost, high return catalyst 
for how mental health problems may be better recognised, understood, 
supported and outcomes improved. The UK NHS and embedded cohort studies 
provide a unique opportunity to field trial this approach to mental health, with 
global reach in terms of both their output and impact. 
  
  
WHAT IS DATA SCIENCE? 
Data science is the extraction of knowledge from high-volume data, using skills 
in computing science, statistics and the specialist domain knowledge of experts.1  
Data science pervades global business and modern living and can partner 
technical revolutions, such as medical genomics and imaging, to revolutionise 
the monitoring, diagnosis, treatment and prevention of disease. This ideal of 
interdisciplinary, evidence-based, data-driven precision medicine is implicit in 
the research strategies of major funding organisations. The case for data science 
is often made for cancer, heart and infectious diseases and yet, mental disorders 
rarely feature as first line targets. Here we argue that it is time to recognise the 
enormous potential for data science to transform mental health research and 
clinical practice. 
 
Figure 1: What is data science? 
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WHY MENTAL HEALTH AND WHY NOW? 
Mental disorders are arguably the greatest ‘hidden’ burden of ill health, with 
substantial long-term impacts on individuals, carers and society.2 People with 
these conditions are often socially excluded3 and less likely to participate in 
research studies or adhere to follow up.4–6 Complexities around defining 
diagnoses present challenges for research into mental health conditions and thus 
enhanced longitudinal datasets are needed to supplement observational 
research. Data science offers an unprecedented opportunity not only for more 
robust diagnostics, but also the prediction of outcome, treatment response, and 
patient preferences to inform interventions.7 It may also provide more effective 
targeting of recruitment to observational and interventional studies. Such data 
are large in size and dimensions and require the application of analytical 
techniques, such as machine learning, where more conventional techniques are 
less computationally tractable.  
 
A key issue in data science is the description of data types that are the most 
informative, most readily available and most easily and efficiently captured. 
Generic data types include electronic health and prescribing records, education, 
welfare, socio-demographic, laboratory and real world monitoring through 
wearable devices and environmental sensors. More specific data might include 
genomic data, in vivo brain imaging and cognitive/behavioural/psychological 
traits. Important challenges should be recognised, which include shortcomings in 
dataset completeness and linkage potential, as well as acceptability to patients 
and the wider public, given the perceived sensitivity of mental health data. It is 
also important to consider the types of information that can, in the round, create 
new ways of classifying mental health and illness. 
 
WHAT RESOURCES DO WE HAVE IN THE UK? 
Within the UK we have rich resources for data science in mental health. In this 
rapidly moving field, we have selected a few exemplars for data science in the 
UK. Whilst these examples give an indication of the range of current resources, 
they also provide a template from which to shape the profile of data science for 
mental health in future years. 
 
1. Population cohorts 
There are several UK population cohorts with enhanced clinical, biological and 
social datasets linked to routinely collected electronic data. UK Biobank 
(www.ukbiobank.ac.uk) and Generation Scotland (www.gen.scot) are two 
examples which illustrate the range of possibilities available. 
 
UK Biobank  
UK Biobank is a cohort study of 502,000 individuals aged between 37 and 73 
years who were recruited from 2006 to 2010. Participants attended an 
assessment centre, completed a touch-screen questionnaire, underwent a nurse-
led interview, and took part in several assessments. These included measures of 
depressive symptoms, psychological distress, cognitive function and alcohol and 
cigarette use. In addition, linkages have been made to National Health Service 
(NHS) healthcare episode data, and a number of biological measures have been 
taken, including DNA for whole-genome genotyping. An initial pilot medical 
imaging study includes unprocessed brain structure, function and connectivity 
data in over 5,000 participants, which is in the process of being extended to 
100,000 individuals. Further longitudinal and outcome assessments include 
repeat cognitive testing and actigraphy. Lifetime history of mental illness will be 
assessed in greater depth with a web-based questionnaire. UK Biobank thus 
brings unprecedented deep and broad phenotyping to mental health research.8  
 
Generation Scotland  
The ‘Generation Scotland: Scottish Family Health Study’ (GS:SFHS) is a 
community and family based study of ~24,000 participants aged between 18 
and 98. Participants were recruited from ~7,000 family groups9,10 with approval 
for medically relevant research, including genetic studies, and for re-contact. 
Questionnaire-based family history and demographics; detailed clinical data; 
validated measures of pain, cognition and mental health; pedigree information; 
and biological samples are available for 21,516 participants. All GS participants 
have consented to allow linkage to their medical record including all routine 
Scottish Morbidity Records, NHS prescriptions, mortality records and the Scottish 
Birth Record. Genetic and phenotypic data are held separately and de-identified. 
Whole-genome data is also available, and serum and urinary proteomics studies 
are under development. All participants were screened for lifetime depression: 
2,706 participants (13.5%) met the DSM IV criteria for major depressive 
disorder (MDD).11 Participants are currently being re-contacted for 
questionnaire-based assessment and further clinical and brain imaging 
measures.  
 
2. Domain specific cohorts linked to routinely collected data (NCMH and 
SAIL Databank) 
In contrast to population based research cohorts, several UK resources are 
focussed specifically on Mental Health and routinely collected clinical data from 
the NHS, the UK’s comprehensive healthcare provider. These data may be more 
representative of the general population and provide a framework for 
implementation.  
 
NCMH and SAIL Databank 
The National Centre for Mental Health (NCMH) was established in Wales in 2011 
and supports and performs high quality research into the causes and treatment 
of mental illness and learning disability (www.ncmh.info). The NCMH continues 
to expand a lifespan-wide cohort of 6000 participants, crossing multiple 
diagnostic categories, willing to participate in research who have consented to 
further contact. Recruitment involves collection of participant information (e.g. 
demographic, clinical, neuropsychological and imaging), routine clinical NHS 
secondary care data and biological materials.  
NCMH has subsequently developed a research platform and infrastructure for 
mental health research in Wales. The NCMH cohort can now be linked to routine 
data nested within prevalent diagnostic cohorts. These cohorts can be tracked 
across healthcare settings, whilst protecting privacy, through linkage to routine 
electronic health and social datasets from the Secure Anonymised Information 
Linkage (SAIL) databank (www.saildatabank.com).12,13  
 
The SAIL databank is a research data repository for Wales, holding over 2Bn 
anonymised health records from ~3.5M patients. Primary care data include 
demographics, diagnoses, symptoms, referrals, laboratory investigations and 
prescriptions. Linkage to the hospital inpatient database provides information on 
admissions, diagnoses, surgery, treatment and discharges. Coverage of 
outpatient appointments, emergency attendances, child health, educational 
attainment, cause-specific mortality, deprivation and urbanicity are also 
recorded. Use of data is conducted in accordance with data protection and 
information governance legislation using a split file approach. 12,13  
 
3. Electronic health record derived cohorts and the Farr Institute 
The increasing use of electronic health records is creating databases unparalleled 
both in sample size and in the depth of information contained. The use of these 
data for research is encouraged by policy14,15 subject to technical and ethical 
considerations.16–21  
 
An important distinction is made between structured information and 
unstructured text – the former being simpler to analyse, albeit that clinical 
uncertainties are often poorly coded. 22–26 Here, text mining may need to be 
employed alongside structured information to better define groups.18,27 
Structured information on patients requiring specialist care has been collected 
systematically by the NHS since 1981 through Hospital Episode Statistics in 
England, the Scottish Morbidity Record and Patient Episode Data for Wales. 
These are available to researchers as linked-data and are published in open-
access aggregated form,28,29 along with primary care data related to the Quality 
Outcomes Framework and Increasing Access to Psychological Therapies.30 
Despite concerns about the speed and accuracy of these data,31–33 these 
resources may prove valuable for measuring real-world outcomes and assessing 
their mediators and predictors.  
 
In 2013 electronic medical record linkage was given further impetus by the 
founding of the UK Farr Institute for Health Informatics Research. It has the aim 
of harnessing health data for patient and pubic benefit by facilitating the safe 
and secure use of electronic patient records and other population based data 
sets.  
 
CRIS  
The Clinical Record Interactive Search (CRIS) application was developed at the 
South London and Maudsley NHS Foundation Trust (SLAM) in 2007 as a means 
of rendering the large volumes electronic mental health record data available for 
research.34,35 CRIS at SLAM accesses mental health case records from around 
260,000 patients within a south London geographic catchment of approximately 
1.2m residents; replications of CRIS have recently become operational 
elsewhere in London, Oxford and Cambridge. Key to the development are not 
only the data structuring and de-identification pipeline afforded by CRIS itself, 
but also the wider data security and governance model which has been patient-
led from the outset.36 Research applications have included searches to help 
identify and characterise rare scenarios for further investigation,37,38 and data 
linkage projects to characterise physical health outcomes.39,40 Recent 
enhancements include the development of natural language processing 
applications to derive structured information from the text fields present in the 
electronic mental health record. These include recorded diagnoses, cognitive test 
scores, pharmacotherapy and symptom profiles.41–46 
 
Child Mental Health: The Child Outcomes Research Consortium approach 
The Child Outcomes Research Consortium (CORC) is a practice research network 
of >50% of all child mental health providers in the UK (~70 organisations) with 
collaborators in Scandinavia and Australia. Members of this not-for-profit 
collaboration share pseudonymised child-level data annually, which are held by 
CORC centrally and consist of ~250,000 care episodes over ten years. The 
collaboration includes health and education providers and the voluntary sector. 
There is an initiative supported by the Department of Health to support closer 
data linkage between these datasets in future.47 The CORC approach is an 
example of both the opportunities and the challenges in collecting and using 
routinely collected data from mental health service providers, and the use of 
‘deep domain knowledge’. CORC is committed to use of the data to inform 
“Precision Mental Health”48 whilst also being mindful of the complexities, 
limitations and flaws in the data.49 CORC draws on this data to support clinical 
decision-making, performance management, quality improvement and specific 
research studies.  
 
Linkage to ‘real-time’ health data and wearable devices 
The increasing use of wearable devices, such as activity monitors, smartphones 
and watches has provided a vast new source of health data. One of the main 
advantages is the rapid availability of ‘real-time’ data (e.g. steps and sleep 
patterns), which can include contemporaneous measures of heart rate, mood, 
diet, sleep and biochemistry. Access to personally generated data can be 
provided through smartphone or web-based applications that collect data from 
individuals, analyse them and provide consent to external researcher’s data 
requests. Companies such as Apple (Healthkit and Researchkit) and Google 
(Alphabet) are developing health based applications and wearable devices, as 
part of a wider array of environmental sensors, ‘The Internet of Things’, and 
health application developer toolkits. This field is at an early stage and there are 
good examples of such initiatives in psychiatry. For example, Truecolours 
(https://oxfordhealth.truecolours.nhs.uk/www/en/) is a platform that has been 
developed to capture continuous patient-generated data with the required 
usability and acceptability to permit reliable longitudinal follow-up. It is our 
opinion that wearables and real-time data have the potential to transform 
disease monitoring, the relationship between patients and their healthcare 
providers and provide new insights into the phenotype and neurobiology of 
mental disorders.   
 
PUBLIC TRUST AND CLINICAL GOVERNANCE 
Government administrative and healthcare data represent major resources for 
research and health service improvement. However, public support, public trust 
and governance arrangements are fundamentally important if their full potential 
is to be realised. There is a need for researchers, clinicians and policy-makers to 
engage with patients and the public in discussions about the potential benefits of 
research and risks of identification or privacy breaches. Several organisations 
are leading projects in the UK, including the Farr Institute (#datasaveslives), the 
European Data in Health Research Alliance (datasaveslives.eu) and 
Patients4Data (patients4data.co.uk). These campaigns engage with the public 
and policymakers to promote the power of patient data and influence regulatory 
authorities to allow continuing use of data for patient and public benefit. These 
initiatives have the potential to shape research questions and ensure these are 
meaningful for communities and patient groups, and will help to ensure 
sustainability. Such activity also sets the work within a wider public context and 
will improve visibility, transparency, and acceptability. 
 
Health data are personal and sensitive, and attitudes research suggests that 
mental health data are among the most sensitive.50,51 Existing initiatives 
demonstrate that substantive patient involvement from the start (in the design, 
implementation, use and development of data-sharing initiatives), can help to 
ensure that meaningful progress is made.35 It is important to attend to the 
growing body of research that helps us to understand the diverse reasons why 
people might be reluctant or unwilling to consent to the use of their data for 
mental health research.52,53 Studies indicate, encouragingly, that a majority of 
mental health service users agree to the use of their health records for research 
– particularly when efforts to engage in on-going communication about their use 
and potential benefits are made.35,54 There may be lessons to be learned from 
cancer research, which has been transformed from being characterised by 
stigma and under-funding into a highly successful global research movement.  
  
Safe and transparent models of governance for re-use of mental health data are 
essential for developing and maintaining public trust. Systems have successfully 
been developed that protect privacy whilst enabling research in the public 
interest. In the future, innovations that allow the public further control over their 
data may offer further opportunities, such as dynamic models of consent55 and 
crowdsourcing (e.g. www.PatientsLikeMe.com). The recently established Farr 
Institute includes a programme of public engagement with a focus on the safe 
and transparent use of patient and research data. 
 
The ‘Scottish Model’ 
Scotland is known to have some of the best administrative and care data in the 
world. In recent years, Scotland has developed an approach which has 
successfully delivered a number of informatics projects involving academia, 
industry and health service providers. One major reason for this success is the 
Community Health Index (CHI) - a unique identifier for approximately 99% of 
the population, facilitating pseudonymised linkage between health and 
administrative data (Figure 1). 
 
Figure 2. National level data resources in Scotland56 
 
Insert Figure 2 here 
 
The ‘Scottish model’ is an exemplar of how to ensure trustworthy data 
governance and engage with the public to drive forward health informatics 
research. Since 2002, the Scottish Government have had an engagement group 
to ensure public input into activities such as reviewing grant applications, 
providing lay research summaries and wider dissemination activities. 
Consultation work since then suggests that the public is content to offer support 
for the use of administrative and health data in research, provided there are 
robust processes to ensure that data security and limited access to trusted 
personnel conducting research for public benefit. It appears that the public is 
more supportive of academic and clinical research than work conducted by 
commercial organisations.50,57  
 
All the outputs generated are scrutinised to ensure they do not identify 
individuals or breach privacy before being released. Plain English summaries of 
research are published online and open access publication is a condition of all 
research. Support to researchers throughout this process is provided by a 
‘research coordinator’ within an eData Research and Innovation Service.56 The 
key elements of the Scottish model are illustrated within Figure 2. 
 
The role of medical research charities 
The role of research charities in the evolution of data access and utilisation is 
still emerging. Recent activity, led by the Association of Medical Research 
Charities has been focused at the national and international level, advocating for 
clearer statutory guidelines on oversight and accountability for NHS England as 
well as ensuring access to data for research purposes in European Union Data 
Protection legislation. As facilitators of a UK-wide discussion of research 
opportunities and challenges in mental health data science, MQ is working with 
charities and government to ensure that mental health is represented in critical 
discussions.  
 
 
TRAINING, RESOURCE AND CAPACITY IMPLICATIONS 
 
1. Technological resource 
The capacity of data storage and access, and the personnel to collect and 
analyse data (and financing to maintain these) are rate-limiting steps in the 
ongoing development of data science. Routinely-collected ‘administrative’ and 
health data tend to be centrally financed by government but have limited 
phenotypic coverage and have, until recently, been used mainly for planning. 
More detailed phenotyping is possible in routine clinical data, such as CRIS in 
London and PsyCIS in Glasgow,58 and large scale genetic, ‘-omics’ and 
neuroimaging studies generate huge volumes of data that pose tractable data 
storage issues. The combination of these datasets is very challenging and 
requires data harmonisation and for compatibility issues to be addressed.  
 
Databases need to gather and hold data, and enable users to search for and 
access data of interest to them. Agreements about data sharing and how to 
facilitate collaboration and innovation are key issues for data scientists. In 
practice, data generation projects are deciding on a case by case basis what 
they they will offer to centralised depositories without offering a coordinated 
solution for how that data will be linked to other sources.  Centralised databases 
can make themselves more attractive to data depositors by offering managed 
data access and trusted analysis environments. Existing examples, focussed on 
genetics, include the Global Alliance for Genomics and Health (GA4GH 
https://genomicsandhealth.org) and RD-Connect (http://rd-connect.eu). 
 
2. Skills resource 
Identifying, training and fostering a generation of clinically-informed data 
scientists from a wide range of backgrounds must be a top priority. This requires 
multidisciplinary training programmes, which expose scientists, informaticians 
and statisticians to commonly used clinical data, diagnoses and treatments, as 
well as a range of relevant methodological approaches. Data scientists will 
usually need further postgraduate training in statistics and computational 
modelling. All trainees will need to be familiar with ethical and regulatory 
requirements as well as prepared to become familiar with the diverse ways in 
which health data are recorded and stored. Given the diversity of resources and 
methodologies, a variety of approaches seems inevitable and desirable. 
Particular care and attention to the career structure of data scientists will be 
needed to nurture early-career researchers and ensure that expensively 
acquired expertise is not lost after training. A spectrum of skills and disciplines 
needs to be present in a data science team and its leadership as well as a 
common understanding of the need for complementary expertise. As data 
science evolves in fields such as engineering and finance, there will be 
opportunities to learn from their experience. 
 
3. National and international collaboration 
There is a need to develop and maintain international and interdisciplinary 
databases and the networks to support their efficient use. There is much work to 
be done in standardising assessments, outcome measures and terminology 
within, let alone between, nations. MQ has recently established UK-based 
research charity with international reach dedicated to mental health 
(www.joinmq.org). MQ and other research charities such as the Wellcome Trust 
and Medical Research Council have an important role to play in matching 
researchers and their research questions to datasets spanning multiple subject 
domains and countries. Routine health record data with detailed mental health 
coverage include those stored by the Information and Statistics Division of the 
Scottish Government, a similar resource in Australia and the exemplary 
Scandinavian systems. Some projects, like UK Biobank, encourage external data 
analysis even as data are being collected, whereas others will not be openly 
shared until the original funder-approved aims have been met. Subject to 
regulatory approvals, it is desirable that systems should be put in place to 
facilitate the incorporation of data from time-limited projects as soon as 
practicable. Intellectual property and resource considerations may make this 
challenging. Fostering collaborations, developing safe havens to facilitate joint 
working and convening advisory groups with wide representation will help  
enhance complementarity across projects and data collections. 
 
OUR VISION OF THE FUTURE 
Against a backdrop of no fundamentally new pharmacologic treatment in the 
past 60 years and a progressive pharmaceutical industry withdrawal from mental 
health Research and Development, an alternative course is essential. Mental 
health remains the leading area of unmet medical need in the developed world, 
and is rapidly acquiring the same status in the developing world.  
 
Combining large healthcare and administrative datasets with real-time 
monitoring, laboratory, genomic and imaging data could achieve a step change 
in the way healthcare is provided and research is organised. In our opinion, data 
science will greatly enhance our ability to conduct discovery science, 
epidemiological studies, personalised medicine and plan services. Without the 
better understanding of mental health problems that will come with use of Big 
Data, longer term visions for self-management, better treatments and learning 
health systems will not be possible. It is thus vital that current initiatives in data 
science recognise and support this need.  
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Legend to Figure 1 What is data science: 
Figure showing the component features of data sciences 
 
Legend to Figure 2: The ‘Scottish’ Model 
Figure shows the linkable data sources available in Scotland, whose 
linkage is facilitated by a unique identifier: the CHI number 
 
Legend to Figure 3: How and where data science can improve 
psychiatric diagnosis and optimise care 
Currently, diagnosis depends upon a self-reported check list following 
DSM and ICD criteria. The patient will normally present in primary care 
and be diagnosed by a GP. The care pathway recommended may vary 
from monitoring only, self-help, counselling or drug prescription. Only a 
minority of patients with a confirmed diagnosis will respond to the initially 
selected intervention.  Severe cases will be referred to secondary care and 
the process refined, but a significant minority will remain treatment 
refractive after testing all available therapies. There are currently no 
robust methods to stratify patients within a given diagnostic category that 
supports treatment choice or predicts treatment outcome. Counselling is 
resource limited and costly compared with drug prescription and this 
influences health practitioner decision making.  The figure highlights in 
bold how data science could provide robust methods to stratify patients 
within a given diagnostic category that can support treatment choice and 
predict treatment outcome (disease stratification and precision medicine). 
The approach builds upon and extends beyond the NIMH Research 
Domain Criteria (RDoC) principles (http://www.nimh.nih.gov/research-
priorities/rdoc/index.shtml ).  Indicative, non-exhaustive data sources are 
listed as inputs towards refined diagnostic classification, optimal choice of 
first line treatment, development of better treatments and monitoring of 
response. Implicit in this refined approach is that a) multiple relevant data 
types and sources are readily available at low cost, b) advance 
epidemiological, statistical, and machine learning data analytics can 
extract the maximally informative variables, c) the chronic and remitting 
course of mental illnesses highlights the added value of objective 
longitudinal and real-time data, for input and feedback to patients, 
practitioners and carers, d) individual personal predictions and care-
pathway monitoring will benefit from similarity matching within patient 
cohorts and against population norms.  
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